About us | ST Diagnostic

ST INNOVATIVE DIAGNOSTICS

ST Innovative diagnostics’ team of leading experts in the fields of cancer, hematology & molecular biology, have collaborated to reveal a significant discovery in the non-invasive detection and monitoring of malignancies.

Harnessing the expertise of trailblazing professionals in cancer, hematology, and molecular biology, the dynamic team at ST Innovative Diagnostics has united their talents to unveil a momentous breakthrough in non-invasive detection and monitoring of malignancies.

OUR MISSION

ST-Innovative Diagnostics aims to provide a multi-cancer early detection, screening & monitoring solution based on its novel proprietary non-invasive blood biomarker

OUR JOURNEY

Over a span of 14 years, an extensive research endeavor was undertaken at Rabin Medical Center and Tel-Aviv University in Israel, under the leadership of Dr. Esther Rabizadeh (PhD).

The outcome was the development of an innovative non-invasive blood test, designed in correlation with PET/CT imaging to effectively monitor malignancies.

This research journey included 13 years of clinical validation involving 125 Non-Hodgkin Lymphoma patients, marked by extensive collaboration with Israel's foremost Medical Centers.

The culmination of this effort resulted in securing 5 patents across the US, Europe, China, and Israel.

Presently, the primary focus lies on the commercial production of the Lymfollow kit, which not only serves as a valuable companion diagnostic test for assessing the efficacy of novel cancer treatments but also holds the potential for wider screening applications in predicting malignancies.

LEADERSHIP

DR. ESTHER RABIZADEH, PHD

Founder & CSO

Dr. Esther Rabizadeh is a highly accomplished expert in the fields of hemato-oncology and cell biology. With a distinguished career spanning decades, she served as the Managing Director of Hematology Laboratories at Rabin Medical Center and headed the Hemato-Oncology research team at the Felsenstein Medical Research Center (FMRC), Tel-Aviv University.

Dr. Rabizadeh's research contributions have been published in prestigious journals, including the Journal of Cancer Research Clinical Oncology, Cancer Research, Clinical Research, Experiment Oncology, and PLOS One, solidifying her reputation as an influential figure in her field.

Her recent focus the activity of Fibrinogen Like Protein 2 (FGL2) in malignancies, culminated in the creation of a revolutionary non-invasive predictive blood biomarker. This biomarker proficiently tracks malignancies and exhibits a robust correlation with PET/CT imaging.

Dr. Rabizadeh's remarkable work has led to five impactful publications and the acquisition of patents in the United States, Europe, China, and Israel, demonstrating her significant contributions to cancer research and patient care.

SHEILA ALTMAN, LLB, MBA

CEO

A seasoned business manager and strategist, with a track record of growing businesses & products, through a unique blend of technological, business, and legal proficiencies within C-Level roles.

Sheila has over 15 years of experience in multinational corporates as well as startups, leading product, business & corporate growth strategies.

Sheila holds a Law degree from Tel-Aviv University, complemented by a MBA from Reichman University and is a member of the Israeli Bar since 2000.

BUSINESS AND ADVISORY TEAM

DANA COHEN, MSC

Advisory board

Possessing extensive expertise within both the private and public biotech sectors, Dana Cohen serves as a seasoned senior manager.

Additionally, Dana fulfills roles as an advisor to biotech organizations in Israel and the USA, while also providing business mentorship to institutions such as Tel Aviv and Bar Ilan Universities, as well as incubators and venture capitalists.

With a background in securing capital and a wealth of experience in navigating local and EU governmental funding opportunities, Dana Cohen brings a multifaceted perspective to her endeavors.

Dr. NIR SHTAYER , DVM

Advisory board

Leveraging over 20 years of global experience in both the pharmaceutical/Biotech industry and higher education sector, incl. MNCs (Omrix J&J, TEVA), Start-ups (PolyPid, Bonus BioGroup, CaVnox) and a Biotechnology Research Center of Excellence (UTS, Australia).

Former Head of Regulatory Affairs and Clinical Departments (Bio-pharmaceutical/Medical Device), including in Teva Pharmaceuticals.

Graduated as a Veterinar, D.V.M (the Koret, Veterinary School, University of Jerusalem, Israel) and holds an Executive MBA (from UTS, Australia).

MATAN RABIZADEH, LLB, BA

Advisory Board

A seasoned business executive within global corporations, Matan is experienced in launching of new ventures and driving business and product growth.

Beyond his corporate roles, Matan also serves as a dedicated advisor, offering invaluable business mentorship to numerous early-stage companies.

Matan is the Israeli liaison for Excell Partners, a venture capital fund backed by the state of New York. Matan Holds LL.B in Law and B.A in economics from the college of management.

SCIENTIFIC & MEDICAL ADVISORY

DR. IZHACK CHERNY, PHD

Scientific Advisor

Dr. Izhack Cherny is a seasoned investigator in the domains of biochemistry and hematology, boasting a doctoral degree from Tel Aviv University's Biotechnology department, alongside post-doctoral education accomplished at Princeton University's Chemistry Department in New Jersey.

With extensive proficiency in proteinaceous systems within the realm of biology, Dr. Cherny possesses a wealth of expertise encompassing protein functionality, structure, enzymology, interactions, engineering, the screening and formulation of inhibitors as well as cancer biology.

PROF. PIA RAANANI MD

Medical Advisor

Prof. Pia Raanani MD is Head of the Division of Hematology at the Rabin Medical Center. She is Clinical Full Professor in Hematology at the Tel-Aviv University.

Prof. Raanani is on the Editorial board of several international hematology journals. Since 2015 she has served as Ambassador for Israel of the MD Anderson Society of Hematologic Oncology.

JUDITH CHEZAR, PHD

Scientific Editor

Former Director of Galilee Medical Center's Hematology Institute’s Laboratories. Oversaw a comprehensive range of labs encompassing General Hematology, Coagulation, Blood Bank, Flow Cytometry, and Molecular Biology dedicated to Hematological disorders.

Contributed expertise as a member of the Advisory Committee to the Ministry of Health, specializing in Transfusion Medicine.

Played a pivotal role as a co-organizer of the Flow Cytometry Forum within the Israel Society for Clinical Laboratory Sciences (ISCLS).

NURIT ROSENBERG, PHD

Medical Advisor

Accomplished professional with a robust background in Hematology.

Currently serving as a Senior Lecturer at the Sackler Faculty of Medicine, Tel-Aviv University, Israel.

A seasoned researcher with a notable tenure (1993-2021) at the Amalia Biron Research Institute of Thrombosis and Hemostasis, Tel-Aviv University.

Former head of the Coagulation Laboratory at both the Hemophilia National Center and Sheba Medical Center, Tel-Hashomer, from 2014 to 2020.

Currently serving as a Coagulation Counselor in the Blood Bank at Sheba Medical Center, Tel-Hashomer, offering expert insights in the realm of coagulation.

SUPPORTED BY:

KEY OPINION LEADERS & ESTEEMED CLINICIANS

CLINICIANS & VOCs

Rabin Medical Center, Petah Tikva

Dr. Ronit Gurion, MD

Soroka Medical Center, Beer Sheva

Dr. Itai Levi

Meir Medical Center, Kfar Saba

Dr. Gilad Itzhaki, MD

Rambam Medical Center, Haifa

Dr. Shimrit Ringelstein Harlev , MD

Shaarei tzedek Medical Center, Jerusalem

Prof. Yishai Ophran, MD

Kaplan Medical Center, Rehovot

Dr. Lev Shvidel, MD

Galilee Medical Center, Nahariya

Dr. Luiza Akria, MD

Key Opinion Leaders (KOLs )

Prof. Jakobe Rowe, M.D

Prof. Yishai Ofran, M.D

Prof. Pia Raanani, M.D

Prof. Anat Gafter-Gvili, MD